Viewing Study NCT05780034


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-29 @ 4:46 AM
Study NCT ID: NCT05780034
Status: RECRUITING
Last Update Posted: 2025-10-02
First Post: 2023-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Sponsor: Accutar Biotechnology Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module